TotalMarketCap

Bristol Myers Squibb

BMYNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$129.258 B

$63.24 -1.49%

Close of 6 Nov 2026

As of 6 Nov 2026, Bristol Myers Squibb (BMY) has a market capitalization of $129.3B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$48.2B

#86 by revenue

Earnings

$7.05B

#70 by earnings

Shares outstanding

2,044,085,831

Latest filing cover page

P/E ratio

18.3

Cap ÷ net income

Other share classes

Bristol Myers Squibb lists more than one class of stock. Company figures above cover all classes combined.

CELG-RI

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #9PfizerPFE$170.5B
  2. #10Vertex PharmaceuticalsVRTX$137.7B
  3. #11Bristol Myers SquibbBMY$129.3B
  4. #12SanofiSNY$114.3B
  5. #13GSKGSK$101.9B

What if Bristol Myers Squibb were worth as much as…

Open the what-if tool →

Gold $28.2T

$13,813.94

Per share 218× higher

Bitcoin $1.53T

$747.45

Per share 11.8× higher

Apple $5.02T

$2,453.80

Per share 38.8× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for Bristol Myers Squibb are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.